Publications by authors named "Valery Attignon"

10 Publications

  • Page 1 of 1

Molecular Characterization of Ovarian Yolk Sac Tumor (OYST).

Authors:
Khalil Hodroj Aleksandra Stevovic Valery Attignon Domenico Ferraioli Pierre Meeus Sabrina Croce Nicolas Chopin Lea Rossi Anne Floquet Christine Rousset-Jablonski Olivier Tredan Frédéric Guyon Isabelle Treilleux Corinne Rannou Marie Morfouace Isabelle Ray-Coquard

Cancers (Basel) 2021 Jan 9;13(2). Epub 2021 Jan 9.

Centre Léon Berard (CLB), 69008 Lyon, France.

View Article and Find Full Text PDF
January 2021

Therapeutic relevance of molecular screening program in patients with metastatic sarcoma: Analysis from the ProfiLER 01 trial.

Authors:
Patrick Arnaud-Coffin Mehdi Brahmi Hélène Vanacker Lauriane Eberst Olivier Tredan Valery Attignon Daniel Pissaloux Emilie Sohier Philippe Cassier Gwenaelle Garin David Pérol Jean-Yves Blay Armelle Dufresne

Transl Oncol 2020 Dec 18;13(12):100870. Epub 2020 Sep 18.

Department of Medical Oncology, Léon Bérard Cancer Center, Lyon, France. Electronic address:

View Article and Find Full Text PDF
December 2020

MLH1 promoter hypermethylation: are you absolutely sure about the absence of MLH1 germline mutation? About a new case.

Authors:
Caroline Kientz Fabienne Prieur Alix Clemenson Marie-Odile Joly Marie-Laure Stachowicz Jessie Auclair Valéry Attignon Renaud Schiappa Qing Wang

Fam Cancer 2020 01 19;19(1):11-14. Epub 2019 Nov 19.

Centre Léon Bérard, Cancer Genomics Platform, 69272, Lyon cedex 08, France.

View Article and Find Full Text PDF
January 2020

Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme.

Authors:
Romain Varnier Olivia Le Saux Sylvie Chabaud Gwenaëlle Garin Emilie Sohier Qing Wang Sandrine Paindavoine David Pérol Christian Baudet Valéry Attignon Daniel Pissaloux Pierre Heudel Benoit You Cécile Leyronnas Olivier Collard Olivier Trédan Nathalie Bonnin Jérôme Long Jean-Philippe Jacquin Philippe A Cassier Olfa Derbel Gilles Freyer Alain Viari Jean-Yves Blay Isabelle Ray-Coquard

Eur J Cancer 2019 09 24;118:156-165. Epub 2019 Jul 24.

Medical Practices Evaluation Team - HESPER EA7425, Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon 1, Lyon, France; Department of Medical Oncology, Centre Léon Bérard, Lyon, France. Electronic address:

View Article and Find Full Text PDF
September 2019

Activity of cabozantinib in radioresistant brain metastases from renal cell carcinoma: two case reports.

Authors:
Sylvie Négrier Guillaume Moriceau Valéry Attignon Véronique Haddad Daniel Pissaloux Nicole Guerin Christian Carrie

J Med Case Rep 2018 Nov 25;12(1):351. Epub 2018 Nov 25.

Department of Radiation Therapy, Centre Léon Bérard, Lyon, France.

View Article and Find Full Text PDF
November 2018

Genetic alterations and tumor immune attack in Yo paraneoplastic cerebellar degeneration.

Authors:
Mathilde Small Isabelle Treilleux Coline Couillault Daniel Pissaloux Géraldine Picard Sandrine Paindavoine Valery Attignon Qing Wang Véronique Rogemond Stéphanie Lay Isabelle Ray-Coquard Jacobus Pfisterer Florence Joly Andreas Du Bois Dimitri Psimaras Nathalie Bendriss-Vermare Christophe Caux Bertrand Dubois Jérôme Honnorat Virginie Desestret

Acta Neuropathol 2018 04 3;135(4):569-579. Epub 2018 Jan 3.

Institut NeuroMyogène, Equipe Synaptopathies et Autoanticorps (SynatAc), INSERM U1217/UMR CRS 5310, Lyon, France.

View Article and Find Full Text PDF
April 2018

Primary Melanoma of the Leptomeninges with BAP1 Expression-Loss in the Setting of a Nevus of Ota: A Clinical, Morphological and Genetic Study of 2 Cases.

Authors:
Gabrielle Goldman-Lévy Valérie Rigau Claire Bléchet Guido Bens Bertrand Muckensturm Manuela Delage François Labrousse Véronique Haddad Valéry Attignon Daniel Pissaloux Arnaud de la Fouchardière

Brain Pathol 2016 07;26(4):547-50

Department of Biopathology, Centre Léon Bérard, 28 rue Laennec, 69008, Lyon, France.

View Article and Find Full Text PDF
July 2016

Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial.

Authors:
Christophe Le Tourneau Jean-Pierre Delord Anthony Gonçalves Céline Gavoille Coraline Dubot Nicolas Isambert Mario Campone Olivier Trédan Marie-Ange Massiani Cécile Mauborgne Sebastien Armanet Nicolas Servant Ivan Bièche Virginie Bernard David Gentien Pascal Jezequel Valéry Attignon Sandrine Boyault Anne Vincent-Salomon Vincent Servois Marie-Paule Sablin Maud Kamal Xavier Paoletti

Lancet Oncol 2015 Oct 3;16(13):1324-34. Epub 2015 Sep 3.

Department of Biostatistics, Institut Curie, Paris, France; Unité INSERM U900, Paris, France.

View Article and Find Full Text PDF
October 2015

The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value.

Authors:
Xiaojun Jiang Daniel Pissaloux Christelle De La Fouchardiere Françoise Desseigne Qing Wang Valery Attignon Marie-Eve Fondrevelle Arnaud De La Fouchardiere Maurice Perol Philippe Cassier Christelle Seigne David Perol Isabelle Ray-Coquard Pierre Meeus Jerome Fayette Aude Flechon Axel Le Cesne Nicolas Penel Olivier Tredan Jean-Yves Blay

Oncotarget 2015 Sep;6(28):26388-99

Department of Translational Research, Centre Leon Berard, 69008 Lyon France.

View Article and Find Full Text PDF
September 2015

Somatic MMR gene mutations as a cause for MSI-H sebaceous neoplasms in Muir-Torre syndrome-like patients.

Authors:
Marie-Odile Joly Valéry Attignon Jean-Christophe Saurin Françoise Desseigne Dominique Leroux Tanguy Martin-Denavit Sophie Giraud Marie-Noëlle Bonnet-Dupeyron Laurence Faivre Jessie Auclair Chloé Grand-Masson Carole Audoynaud Qing Wang

Hum Mutat 2015 Mar;36(3):292-5

Edouard Herriot hospital, Central Service of Pathology, Tumor Biology Laboratory, Lyon, France.

View Article and Find Full Text PDF
March 2015